Archive > Volume 29 Issue 6 > 2022,29(6):587-595. DOI:10.3872/j.issn.1007-385X.2022.06.011 Prev Next

Review

Research progress on the targeted drugs for HER2-positive breast cancer

您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.